Cargando…

Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial

BACKGROUND: Progesterone administration has been shown to reduce the risk of preterm birth and neonatal morbidity in women at high risk, but there is uncertainty about longer term effects on the child. METHODS: We did a double-blind, randomised, placebo-controlled trial of vaginal progesterone, 200...

Descripción completa

Detalles Bibliográficos
Autores principales:	Norman, Jane Elizabeth, Marlow, Neil, Messow, Claudia-Martina, Shennan, Andrew, Bennett, Phillip R, Thornton, Steven, Robson, Stephen C, McConnachie, Alex, Petrou, Stavros, Sebire, Neil J, Lavender, Tina, Whyte, Sonia, Norrie, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406617/ https://www.ncbi.nlm.nih.gov/pubmed/26921136 http://dx.doi.org/10.1016/S0140-6736(16)00350-0

Ejemplares similares

Trial protocol OPPTIMUM– Does progesterone prophylaxis for the prevention of preterm labour improve outcome?
por: Norman, Jane E, et al.
Publicado: (2012)

Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta‐analysis including data from the OPPTIMUM study
por: Romero, R., et al.
Publicado: (2016)

Antibiotic prophylaxis in breast cancer surgery (PAUS trial): randomised clinical double-blind parallel-group multicentre superiority trial
por: Stallard, Sheila, et al.
Publicado: (2022)

Open randomised trial of the (Arabin) pessary to prevent preterm birth in twin pregnancy with health economics and acceptability: STOPPIT-2—a study protocol
por: Norman, Jane E, et al.
Publicado: (2018)

Evaluation of the Arabin cervical pessary for prevention of preterm birth in women with a twin pregnancy and short cervix (STOPPIT-2): An open-label randomised trial and updated meta-analysis
por: Norman, Jane E., et al.
Publicado: (2021)

Association of Vaginal Progesterone Treatment With Prevention of Recurrent Preterm Birth
por: Nelson, David B., et al.
Publicado: (2022)

The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk
por: Kindinger, Lindsay M., et al.
Publicado: (2017)

STOPPIT Baby Follow-Up Study: The Effect of Prophylactic Progesterone in Twin Pregnancy on Childhood Outcome
por: McNamara, Helen Christine, et al.
Publicado: (2015)

Progesterone effects on vaginal cytokines in women with a history of preterm birth
por: Garry, David J., et al.
Publicado: (2018)

Addressing the sociotechnical drivers of quality improvement: a case study of post-operative DVT prophylaxis computerised decision support
por: Lesselroth, Blake J, et al.
Publicado: (2011)

Vaginal micronized progesterone capsule versus vaginal progesterone gel for lutheal support in normoresponder IVF/ICSI-ET cycles
por: Sofuoglu, Kenan, et al.
Publicado: (2015)

Counselling versus low-intensity cognitive behavioural therapy for persistent sub-threshold and mild depression (CLICD): a pilot/feasibility randomised controlled trial
por: Freire, Elizabeth, et al.
Publicado: (2015)

Randomised, double-blind, placebo-controlled trials of non-individualised homeopathic treatment: systematic review and meta-analysis
por: Mathie, Robert T., et al.
Publicado: (2017)

Economic costs and health utility values associated with extremely preterm birth: Evidence from the EPICure2 cohort study
por: Achana, Felix, et al.
Publicado: (2022)

Comparing intramuscular progesterone, vaginal progesterone and 17 -hydroxyprogestrone caproate in IVF and ICSI cycle
por: Moini, Ashraf, et al.
Publicado: (2011)

Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence
por: Coomarasamy, Arri, et al.
Publicado: (2020)

Patient reported outcome data following influenza A (H1N1p) vaccination in the 2009–2010 season: web-based and telephone evaluation
por: Wade, Alan G, et al.
Publicado: (2011)

Vaginal progesterone in risk reduction of preterm birth in women with short cervix in the midtrimester of pregnancy
por: Khandelwal, Meena
Publicado: (2012)

Efficacy and safety of oral nifedipine with or without vaginal progesterone in the management of threatened preterm labor
por: Ashraf, Bushra
Publicado: (2019)

Co-administration of GnRH agonists with vaginal progesterone compared to vaginal progesterone in luteal phase support of the frozen-thawed embryo transfer cycle: An RCT
por: Zareii, Afsoon, et al.
Publicado: (2021)

Patients’ administration preferences: progesterone vaginal insert (Endometrin®) compared to intramuscular progesterone for Luteal phase support
por: Beltsos, Angeline N, et al.
Publicado: (2014)

Role of Cervical Cerclage and Vaginal Progesterone in the Treatment of Cervical Incompetence with/without Preterm Birth History
por: Wang, Shao-Wei, et al.
Publicado: (2016)

Vaginal progesterone for prevention of preterm delivery in women with twin pregnancy: a randomized controlled trial
por: Shabaan, OM, et al.
Publicado: (2018)

Correction to “Notification: Prevention of preterm birth: a randomized trial of vaginal compared with intramuscular progesterone”
Publicado: (2023)

Sexual Absorption of Vaginal Progesterone: A Randomized Control Trial
por: Merriam, Kathryn S., et al.
Publicado: (2015)

Oral versus Vaginal Micronized Progesterone for the Treatment of Threatened Miscarriage
por: Parveen, Rashida, et al.
Publicado: (2021)

Efficacy, safety and tolerability of progesterone vaginal pessaries versus progesterone vaginal gel for luteal phase support after in vitro fertilisation: a randomised controlled trial
por: Saunders, Helen, et al.
Publicado: (2020)

Vaginal progesterone pessaries for pregnant women with a previous preterm birth to prevent neonatal respiratory distress syndrome (the PROGRESS Study): A multicentre, randomised, placebo-controlled trial
por: Crowther, Caroline A., et al.
Publicado: (2017)

Comparison of Risk of Preterm Labor between Vaginal Progesterone and17-Alpha-Hydroxy-Progesterone Caproate in Women with Threatened Abortion: A Randomized Clinical Trial
por: Beigi, Abootaleb, et al.
Publicado: (2016)

Comparative Study of Vaginal versus Intramuscular Progesterone in the Prevention of Preterm Delivery: A Randomized Clinical Trial
por: Bafghi, Afsar Sadat Tabatabaei, et al.
Publicado: (2015)

Total Reactive Isocyanate Group (TRIG) Measurement: A Commentary
por: McConnachie, Glen, et al.
Publicado: (2023)

Outcome of Vaginal Progesterone as a Tocolytic Agent: Randomized Clinical Trial
por: Saleh Gargari, Soraya, et al.
Publicado: (2012)

Effects of intramuscular and vaginal progesterone supplementation on frozen-thawed embryo transfer
por: Jiang, Lei, et al.
Publicado: (2019)

Development of Vaginal Carriers Based on Chitosan-Grafted-PNIPAAm for Progesterone Administration
por: Afloarea, Oana-Teodora, et al.
Publicado: (2022)

Baseline characteristics and patient reported outcome data of patients prescribed etanercept: web-based and telephone evaluation
por: Wade, Alan G, et al.
Publicado: (2011)

Neonatal outcomes and delivery of care for infants born late preterm or moderately preterm: a prospective population-based study
por: Boyle, Elaine M, et al.
Publicado: (2015)

Luteal phase bleeding after IVF cycles: comparison between progesterone vaginal gel and intramuscular progesterone and correlation with pregnancy outcomes
por: Jabara, Sami, et al.
Publicado: (2009)

Subcutaneous progesterone versus vaginal progesterone for luteal-phase support in frozen-thawed embryo transfer: A cross-sectional study
por: Aflatoonian, Abbas, et al.
Publicado: (2021)

Vaginal progesterone to prevent preterm delivery among HIV-infected pregnant women in Zambia: A feasibility study
por: Price, Joan T., et al.
Publicado: (2020)

Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertension
por: Barma, Maryam, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8n9h4h737nd9ckre1ldsfnggbr